Molecular pathogenesis of diffuse large B-cell lymphoma.

Overview of attention for article published in Journal of Clinical Oncology, September 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

patent: 82 patents

Readers on

mendeley: 147 Mendeley

So far, Altmetric has seen 82 patents that reference this research output.

Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor

Grant US-12551448-B2

United States of America

Use of inhibitors of Brutons tyrosine kinase (Btk)

Grant US-11672803-B2

United States of America

Crystalline forms of a Bruton's tyrosine kinase inhibitor

Grant US-10961251-B1

United States of America

Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)

Grant US-10954567-B2

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 78 additional patents.